← Back to Search

Virtual Education Program for Atrial Fibrillation

N/A
Waitlist Available
Led By Anil Gehi, MD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient with diagnosis of non-valvular or valvular atrial fibrillation
Age >/= 18
Must not have
Unable to provide informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 1-year post intervention session 6
Awards & highlights
No Placebo-Only Group

Summary

This trial will assess if a virtual education program for adults with AF can lead to improved quality of life and better self-management.

Who is the study for?
This trial is for adults with atrial fibrillation, either non-valvular or valvular. Participants must be 18 years or older and capable of giving informed consent. It's not open to individuals who are incarcerated.
What is being tested?
The 'AF at Home' program is being tested to see if it improves quality of life and self-care in people with atrial fibrillation. Participants will attend six hours of virtual education over three weeks and complete questionnaires before and after the program.
What are the potential side effects?
Since this trial involves an educational program rather than a drug, traditional side effects aren't expected. However, participants may experience fatigue or eye strain from screen time during virtual sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with atrial fibrillation not caused by heart valve issues.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am unable to understand and agree to the study's details on my own.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 1-year post intervention session 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 1-year post intervention session 6 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change Atrial Fibrillation Effect on Quality-of-life Questionnaire (AFEQT) Score
Secondary study objectives
Change in Cardiac Anxiety Questionnaire (CAQ)
Change in Confidence in Atrial Fibrillation Management (CALM) Scale
Change in Patient-Reported Outcomes Measurement Information System 29 (PROMIS-29) Global Pain Intensity Scores
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: AF at HomeExperimental Treatment1 Intervention
All recruited participants will participate in the AF at Home educational intervention.

Find a Location

Who is running the clinical trial?

Bristol-Myers Squibb FoundationUNKNOWN
5 Previous Clinical Trials
1,204 Total Patients Enrolled
1 Trials studying Atrial Fibrillation
526 Patients Enrolled for Atrial Fibrillation
Bristol-Myers SquibbIndustry Sponsor
2,696 Previous Clinical Trials
4,098,771 Total Patients Enrolled
72 Trials studying Atrial Fibrillation
1,650,720 Patients Enrolled for Atrial Fibrillation
University of North Carolina, Chapel HillLead Sponsor
1,569 Previous Clinical Trials
4,319,284 Total Patients Enrolled
3 Trials studying Atrial Fibrillation
755 Patients Enrolled for Atrial Fibrillation
Wake Forest UniversityOTHER
192 Previous Clinical Trials
165,936 Total Patients Enrolled
1 Trials studying Atrial Fibrillation
120 Patients Enrolled for Atrial Fibrillation
Duke UniversityOTHER
2,463 Previous Clinical Trials
2,981,560 Total Patients Enrolled
13 Trials studying Atrial Fibrillation
13,021 Patients Enrolled for Atrial Fibrillation
Anil Gehi, MDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill
2 Previous Clinical Trials
646 Total Patients Enrolled
2 Trials studying Atrial Fibrillation
646 Patients Enrolled for Atrial Fibrillation

Media Library

AF at Home Clinical Trial Eligibility Overview. Trial Name: NCT05810896 — N/A
Atrial Fibrillation Research Study Groups: AF at Home
Atrial Fibrillation Clinical Trial 2023: AF at Home Highlights & Side Effects. Trial Name: NCT05810896 — N/A
AF at Home 2023 Treatment Timeline for Medical Study. Trial Name: NCT05810896 — N/A
~39 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top